ArticleInfectious diseases and therapy2022

Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I Trial.

Yeping Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.